menu search

CHE / Chemed Corporation to Present at the Bank of America Merrill Lynch 2023 Health Care Conference

Chemed Corporation to Present at the Bank of America Merrill Lynch 2023 Health Care Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2023 Health Care Conference on Wednesday, May 10, 2023, at 10:40 AM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentati. Read More
Posted: May 3 2023, 12:00
Author Name: Business Wire
Views: 102152

CHE News  

Chemed (CHE) Q3 Earnings and Revenues Surpass, Margins Rise

By Zacks Investment Research
October 27, 2023

Chemed (CHE) Q3 Earnings and Revenues Surpass, Margins Rise

Chemed's (CHE) third-quarter 2023 performance reflects strength in the VITAS segment. more_horizontal

Chemed Corporation (CHE) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 26, 2023

Chemed Corporation (CHE) Q3 2023 Earnings Call Transcript

Chemed Corporation (NYSE:CHE ) Q3 2023 Earnings Conference Call October 26, 2023 10:00 AM ET Company Participants Holley Schmidt - Assistant Controlle more_horizontal

Chemed (CHE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

By Zacks Investment Research
October 25, 2023

Chemed (CHE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Chemed (CHE) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to com more_horizontal

Chemed (CHE) Q3 Earnings and Revenues Beat Estimates

By Zacks Investment Research
October 25, 2023

Chemed (CHE) Q3 Earnings and Revenues Beat Estimates

Chemed (CHE) came out with quarterly earnings of $5.32 per share, beating the Zacks Consensus Estimate of $4.92 per share. This compares to earnings o more_horizontal

OPCH or CHE: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
October 20, 2023

OPCH or CHE: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed ( more_horizontal

3 Mighty Mid-Cap Stocks Ready to Shine This Fall

By InvestorPlace
September 25, 2023

3 Mighty Mid-Cap Stocks Ready to Shine This Fall

In the current market cycle, where inflation is sticky and central banks weigh their next move, some investors need help choosing which type of stocks more_horizontal

DVA or CHE: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
September 18, 2023

DVA or CHE: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with DaVita HealthCare (DVA) and Chemed (CHE). But which o more_horizontal

Chemed (CHE) Faces Macroeconomic Woes, Tough Competition

By Zacks Investment Research
September 14, 2023

Chemed (CHE) Faces Macroeconomic Woes, Tough Competition

Inflationary trend, increased logistics costs and higher employee-related expenses continue to hurt Chemed's (CHE) growth. more_horizontal


Search within

Pages Search Results: